Pagina 3 - I migliori medici per il trattamento di Linfoma non-Hodgkin - TOP-73 medici

Dr. Abraham Avigdor, MD, is Director of the Institute of Hematology and Co‑Director of the Hematology & Bone Marrow Transplantation Division at Sheba Medical Center. He is an international leader in lymphoma, CAR‑T, and advanced hemato‑oncology with more than 35 years of experience. His clinical focus includes lymphomas, multiple myeloma, and complex blood cancers.

He is a pioneer in CAR‑T integration. He leads cellular therapy and bone marrow transplantation programs (autologous and allogeneic). He also advances stem cell therapies and precision diagnostics, including PET/CT‑based prognostics. His work includes immunotherapy and targeted regimens and the development of innovative, data‑driven protocols.

He collaborates with LYSA, EMCL, and international PET groups. He has authored more than 130 publications. Key roles include Founder and President of the Israeli Lymphoma Working Group, former Chair of the Israeli Lymphoma Study Group, and Senior Lecturer at Tel Aviv University. Education: MD, Ben‑Gurion University; residency, Sheba Medical Center; postdoctoral fellowship, Weizmann Institute. Awards include the Knesset Prize, the Israeli Ministry of Health Award, and the Sackler Prize.

Prof. Elad Jacoby, MD, heads the Pediatric Cell Therapy Center at Sheba Medical Center. He is the Medical Director of the Advanced Biotherapy Center. He is a pioneer of pediatric CAR T‑cell therapy in Israel. He led one of the first national leukemia programs. He has almost 20 years of clinical and research experience.

He specializes in CAR T‑cell therapy, bone marrow and stem cell transplantation, and high‑risk pediatric leukemias and lymphomas. He leads international clinical trials and has authored over 240 publications. His collaborations include Johns Hopkins Hospital and the U.S. National Cancer Institute. He is an Associate Professor at Tel Aviv University. He received his MD from Tel Aviv University, completed residency at Sheba Medical Center, and fellowships at Johns Hopkins and the National Cancer Institute. He is board‑certified in Pediatrics and in Pediatric Hematology and Oncology. He serves on the IBFM CAR T‑Cell Taskforce and the Sheba Institutional Review Board. He leads the integration of CAR T‑cell therapy with transplantation.

Il medico è un oncoematologo esperto specializzato nel trattamento dei tumori del sangue e dei disturbi correlati. Con un focus su terapie innovative e cure personalizzate per i pazienti, il medico ha contribuito in modo significativo ai progressi nel campo. Il medico è affiliato a diverse istituzioni mediche di primo piano e ha pubblicato numerosi articoli di ricerca su riviste peer-reviewed.<\/p>

Il medico è anche attivamente coinvolto in studi clinici che mirano a migliorare i risultati per i pazienti con malignità ematologiche. Certificato in ematologia e oncologia, il medico è riconosciuto per la sua esperienza sia nella pratica clinica che nella ricerca.<\/p>

Con 20 anni di pratica, la dottoressa si specializza in ematologia e oncologia pediatrica, concentrandosi su malattie rare del cancro del sangue. Ha eseguito oltre 3.500 trapianti di midollo osseo, guadagnandosi una reputazione tra i pazienti come colei che "trapianta la vita."

La sua competenza e dedizione sono state riconosciute da Forbes, che l'ha nominata una delle migliori dottoresse nel 2018.

Il medico è uno specialista rinomato in ematologia e trapiantologia, con una vasta esperienza nella gestione di casi complessi che coinvolgono disturbi del sangue e trapianti di organi. Il medico ha contribuito in modo significativo ai progressi in questi campi sia attraverso la pratica clinica che la ricerca. Con numerose pubblicazioni su riviste mediche di spicco, il medico è riconosciuto per aver sviluppato protocolli di trattamento innovativi e migliorato i risultati dei pazienti. Inoltre, il medico ha ricoperto vari ruoli di leadership in prestigiose istituzioni mediche, migliorando la qualità delle cure e dell'educazione in ematologia e trapiantologia.<\/p>

Il medico è specializzato in ematologia con un focus sul trattamento dei linfomi. Con una vasta esperienza in questo campo, il medico ha contribuito in modo significativo ai progressi nel trattamento dei linfomi e nella cura dei pazienti. Il medico è riconosciuto per la sua esperienza e impegno nel migliorare i risultati per i pazienti con disturbi ematologici.<\/p>

Il medico è specializzato in linfomi e leucemia linfatica cronica, guidando innovazioni nell'analisi e nel trattamento delle malattie ematologiche. Rinomato a livello globale per la sua esperienza nella Leucemia Linfatica Cronica (CLL), il medico conduce ricerche cliniche e di base significative, concentrandosi sulla patogenesi molecolare e nuovi approcci terapeutici.<\/p>

Attualmente coinvolto in oltre 80 studi dalla fase 1 alla fase 3, il medico contribuisce allo sviluppo di nuovi farmaci e trattamenti. Come Capo dell'Ematologia presso l'IOB Institute of Oncology e Capo del Dipartimento di Ematologia presso il Vall d’Hebron University Hospital, il medico ha pubblicato oltre 100 articoli su riviste prestigiose.<\/p>

Direttore dell'Unità Linfomi presso il San Raffaele – il Dr. Ferreri ha fondato la Fondazione Italiana Linfomi per avanzare il trattamento dei linfomi.

• Vice Direttore dell'Oncologia Ematologica con oltre 20 anni di esperienza
• Autore di oltre 300 articoli di ricerca sul trattamento dei linfomi
• Membro delle principali associazioni di ematologia e oncologia a livello mondiale
• Specializzato in linfomi non-Hodgkin con un focus di ricerca dedicato

Il Prof. Dr. Serdar Bedii Omay ha pubblicato oltre 65 articoli scientifici sull'ematologia e il trapianto di midollo osseo. Ha svolto la sua formazione presso la Facoltà di Medicina di Mie in Giappone.

• Specializzato in ematologia con oltre 30 anni di esperienza
• Professore presso l'Università di Ege e l'Università Tecnica del Mar Nero
• Esperto in ematologia molecolare
• Ha lavorato in istituzioni prestigiose tra cui la Facoltà di Medicina di Hacettepe

Responsabile di Ematologia e Trapianto di Midollo Osseo presso il San Raffaele – il Professor Ciceri coordina sperimentazioni cliniche di terapia cellulare e genica per i tumori del sangue.

• Ricercatore principale in sperimentazioni cliniche per tumori ematologici
• Ha pubblicato oltre 180 articoli scientifici su ematologia e trapianti
• Membro dell'Associazione Europea di Ematologia e di altre società chiave
• Specializzato in ematologia con vasta esperienza nel trapianto di midollo osseo

Il medico si è laureato presso la Facoltà di Medicina dell'Università di Ankara nel 1992 ed è diventato Specialista in Medicina presso la Facoltà di Medicina dell'Università di Uludağ, Dipartimento di Malattie Infantili. Nel 2002, il medico ha servito come Professore Assistente in Ematologia Pediatrica presso la stessa istituzione.<\/p>

Il medico è specializzato nella diagnosi e nel trattamento dei tumori infantili, della leucemia (linfoma), delle malattie emorragiche infantili, dell'occlusione vascolare, dei trattamenti per l'anemia e delle carenze di ferro e vitamine.<\/p>

Con un forte background accademico, il medico ha pubblicato 15 articoli su riviste internazionali con revisione paritaria, ha presentato 9 testi completi a incontri scientifici internazionali, ha scritto 3 libri o capitoli di libri e ha pubblicato 8 articoli su riviste locali con revisione paritaria.<\/p>

Education

• Undergraduate: Istanbul Faculty of Medicine, Istanbul University, 2007
• MSc (Internal Medicine Department): Marmara University Faculty of Medicine, 2012
• PhD (Hematology Clinic): Istanbul Training and Research Hospital, 2018
• Associate Professor (Hematology Clinic): Prof.Dr.Cemil Tascioglu Training and Research Hospital, 2019

Prof. Dr. Rafet Eren graduated from Istanbul Faculty of Medicine in 2007. He completed his Internal Medicine specialty training at Marmara University Faculty of Medicine in 2012. In 2018, he became a Hematology subspecialist at Istanbul Training and Research Hospital. In 2019, he was awarded the title of Associate Professor in the field of Hematology. Afterwards, he worked as a faculty member at Başakşehir Çam and Sakura City Hospital, Bozyaka Training and Research Hospital and Istinye University (Istinye University Bahçeşehir and Liv Hospital Vadistanbul) and is currently working at Biruni University Hospital. Dr. Rafet Eren is a member of Turkish Society of Hematology, Hematology Specialty Society and European Society of Hematology and speaks English fluently. He has around 50 publications in national and international refereed journals.

Scientific Memberships

• Turkish Hematology Association
• Hematology Specialty Society
• Turkish Internal Medicine Specialty Society
• European Society of Hematology
•  

Awards 

• Young Researcher Award (42nd National Hematology Congress), 2016
• Special Jury Paper Award (3rd Hematologic Oncology Congress), 2015
• Paper 3rd Prize (2nd Hematologic Oncology and Bone Marrow Transplantation Symposium), 2016

Dr. Hilmi Apak is a respected pediatric hematology-oncology specialist with more than 21 years of experience. He is trained in pediatric oncology. Dr. Apak has led advanced treatments, including bone marrow transplantation, leukemia chemotherapy, and CAR T-cell therapy.

He has published 75 international medical articles, showing his strong contribution to pediatric oncology research. Dr. Apak has worked as assistant editor for the Turkish Pediatrics Archives Periodical. He has also held important academic and leadership positions, such as Head of Pediatric Hematology-Oncology at Istanbul University-Cerrahpaşa.

Medical Fields of Interest: 

Chronic Leukemia (Chronic Lymphocytes Leukemia/ Chronic Myeloid Leukemia) 

Chronic Myeloproliferative Diseases (Polistemia Vera, Essential Thrombocytosis, Myelofibrosis etc.) 

Lymphoma (Hodgkin’s and Non-Hodgkin’s) 

Multiple Myeloma 

Education: 

Ege University Faculty of Medicine Medical Doctor 1999 - 2005 

Pamukkale University Specialist in Internal Medicine 2006 - 2011 

Pamukkale University Hematologist 2011 - 2014 

ESCCA Summer School On Cytometry/PRAGUE (May 2014) 

Istanbul Training and Research Hospital Hematology Clinic Associate Professor 2018 

Experience: 

Selçuk University Faculty of Medicine Hospital 2015 

Pamukkale University Internal Medicine Residency Training 2016 - 2011 

Denizli Sarayköy State Hospital 2011 - 2011 

Pamukkale University Hematology Minor Residency Training 2011 - 2014 

Istanbul Training and Research Hospital Hematology Clinic Specialist Doctor 2015 - 2020 

Istanbul Training and Research Hospital Hematology Clinic Responsible Authority 2015 - 2020 

Istanbul Training and Research Hospital Hematology Clinic Responsible Authority/ Lecturer 2019 - 2020 

Istanbul Başakşehir Çam and Şakura City Hospital Hematology Clinic Lecturer 2020 - 2020

Liv Hospital Ulus 2020-

Memberships: 

Turkish Society of Hematology 

The Society of Hematological Education and Research (Member of The Board of Directors

Publications:

32 articles published in international peer-reviewed journals 

12 cases published in international peer-reviewed journals 

11 articles published in national peer-reviewed journals 

5 cases published in national peer-reviewed journals

Education

• Faculty of Medicine - Cerrahpaşa Faculty of Medicine 1999-2005
• Internal Medicine Residency - Istanbul Haseki Training and Research Hospital 2006-2010
• Hematology Subspecialist Dr. Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital - Hematology and Stem Cell Transplant Clinic 2013-2017
• Associate ProfessorIstanbul Ümraniye Training and Research Hospital 2019
•  

Experience

• Assistant Doctor Istanbul Haseki Training and Research Hospital - Internal Medicine Clinic 2006-2010
• Internal Medicine Specialist Istanbul Esenyurt State Hospital 2010-2012
• Internal Medicine Specialist-Military service Samsun Military Hospital 2012-2013
• Subspecialty Training Dr. Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital - Hematology and Stem Cell Transplant Clinic 2013-2017
• Hematology Subspecialist Ankara Gülhane Training and Research Hospital, Hematology and Stem Cell Transplant Clinic 2017-2018
• Hematology Subspecialist Istanbul Ümraniye Training and Research Hospital/Hematology 2018-2019
• Associate Professor Istanbul Ümraniye Training and Research Hospital/Hematology 2019-2021
• Associate Professor Maltepe University Faculty of Medicine / Hematology 2021-2024
• Associate Professor Istanbul VM Medical Park Pendik Hospital / Hematology and Stem Cell Transplant Clinic 2022-2024
•  

Scientific Memberships

• Turkish Medical Association
• Turkish Apheresis Society
• Hematologic Oncology Society
• Blood and Bone Marrow Transplant Association
• Hematologic Immunology Society
•  

Awards

•  
• Hematologic Oncology Society, 2015 - Second Prize for Paper
• Hematologic Oncology Society, 2016 - Second Prize for Paper
• Turkish Apheresis Association, 2016 - Paper Third Prize,
• Hematologic Immunology Association, 2016 - Second Prize for Paper
• Hematologic Oncology Society, 2016 - Second Prize for Paper
• Blood and Bone Marrow Transplantation Association, 2017 - First Prize for Paper
   

Eduardo Fernandez, MD

Medical Doctor & Stem Cell Expert

Dr. Eduardo Fernandez is a distinguished medical professional specializing in stem cell therapies and regenerative medicine. He is a certified member of the Mexican College of Stem Cells and Regenerative Medicine, as well as the Mexican Council of Stem Cells for Therapeutic and Research Purposes. Dr. Fernandez’s certifications are the result of a rigorous 8-hour examination process, reserved for a select group of doctors who possess advanced knowledge and experience in these cutting-edge treatments. With only 50 certified doctors in Mexico, Dr. Fernandez’s expertise is highly sought after and respected.

In addition to his national recognition, Dr. Fernandez is awaiting international certification from the renowned International Society for Stem Cell Research (ISSCR). Membership in this prestigious organization signifies Dr. Fernandez’s extensive experience and expertise in stem cell treatments. The ISSCR includes prominent scientists from renowned universities such as Harvard, Yale, Stanford, and other esteemed institutions worldwide. Being a part of this elite society represents the pinnacle of honor and prestige in the field of stem cell therapies.

Furthermore, Dr. Fernandez is also seeking membership and international certification from the International Society for Extracellular Vesicles (ISEV), the largest community of extracellular vesicle researchers globally. With only two thousand members worldwide, ISEV’s select nature underscores Dr. Fernandez’s exceptional dedication to advancing scientific knowledge in the study of exosomes and cellular messengers. By pursuing membership in ISEV, Dr. Fernandez continues to demonstrate his commitment to staying at the forefront of research and innovation in the field of regenerative medicine.